在中国,抗癌药物价格的时间趋势和区域差异
Jinwei Zhang1,2, Shuchen Hu1,2, Xingyu Liu1,2
1Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
Frontiers in pharmacology
|May 30, 2024
概括
中国政府的政策降低了针对性抗癌药物的价格,但增加了非向性基本药物的价格和区域差异,影响了患者的获取.
科学领域:
- 药物经济学 药物经济学
- 卫生政策分析 卫生政策分析
- 瘤学药物定价 瘤学药物定价
背景情况:
- 高昂的抗癌药物价格阻碍了获取,特别是在发展中国家.
- 中国政府的价格控制政策对抗癌药物的影响尚不清楚.
研究的目的:
- 分析2015年至2022年中国基本抗癌药物价格的时间趋势和区域变化.
- 评估政府关于抗癌药物定价和可获得性政策的有效性.
主要方法:
- 利用了2018年中国国家基本药物清单 (2015-2022) 中的29种抗癌药物的采购数据.
- 使用定义每日剂量 (DDD) 成本计算药品成本.
- 评估了国家价格趋势和省级价格随时间变化的变化.
主要成果:
- 针对性抗癌药物在全国范围内出现了持续的价格下降.
- 几乎一半的非向抗癌药物经历了价格上和扩大区域差异.
- 对于大多数向药物,省级价格变化下降,但对于一些非向药物,价格变化增加.
结论:
- 政府政策成功地降低了针对性抗癌药物的价格和区域差异.
- 非向抗癌药物的价格上和区域差异可能会加剧健康不平等.
- 需要进一步的战略,以确保所有必要的抗癌药物的公平获取.
更多相关视频
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
873
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
01:30Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K